New developments in the management of cytomegalovirus infection after solid organ transplantation (Q37756120)

22 August 2017

1 reference

title

New developments in the management of cytomegalovirus infection after solid organ transplantation (English)

1 reference

22 August 2017

0 references

organ transplantation

1 reference

inferred from title

cytomegaloviral disease

1 reference

Albert J Eid

1 reference

22 August 2017

Raymund R Razonable

series ordinal

1 reference

22 August 2017

publication date

1 May 2010

1 reference

22 August 2017

1 reference

22 August 2017

1 reference

22 August 2017

1 reference

22 August 2017

page(s)

965-981

1 reference

Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients

22 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F10898540-000000000-00000

Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation

21 January 2018

1 reference

12 December 2020

Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients

1 reference

12 December 2020

Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients

1 reference

12 December 2020

A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection

1 reference

12 December 2020

Long-term outcomes of cytomegalovirus infection and disease after lung or heart-lung transplantation with a delayed ganciclovir regimen.

1 reference

12 December 2020

Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections.

1 reference

12 December 2020

Effect of antiviral chemoprophylaxis on adverse clinical outcomes associated with cytomegalovirus after liver transplantation

1 reference

12 December 2020

Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis

1 reference

12 December 2020

Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation

1 reference

12 December 2020

Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients

1 reference

12 December 2020

The impact of human herpesvirus-6 and -7 infection on the outcome of liver transplantation

1 reference

12 December 2020

New-onset diabetes after kidney transplantation: risk factors.

1 reference

12 December 2020

Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation

1 reference

12 December 2020

Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients

1 reference

12 December 2020

Cytomegalovirus infection in renal transplant recipients is associated with impaired survival irrespective of expected mortality risk

1 reference

12 December 2020

Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival

1 reference

12 December 2020

The natural course of cytomegalovirus infection and disease in renal transplant recipients

1 reference

12 December 2020

The antiviral activities of artemisinin and artesunate.

1 reference

12 December 2020

Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial.

1 reference

12 December 2020

The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients

1 reference

12 December 2020

Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation

1 reference

12 December 2020

Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?--A mini-review

1 reference

12 December 2020

Opportunistic Infections in 547 Organ Transplant Recipients Receiving Alemtuzumab, a Humanized Monoclonal CD-52 Antibody

1 reference

12 December 2020

Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV disease

1 reference

12 December 2020

Delayed-onset primary cytomegalovirus disease after liver transplantation

1 reference

12 December 2020

Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients

1 reference

12 December 2020

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

1 reference

12 December 2020

Human Cytomegalovirus (HCMV) Replication Dynamics in HCMV‐Naive and ‐Experienced Immunocompromised Hosts

1 reference

12 December 2020

Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation

1 reference

12 December 2020

Novel mutation in the CMV UL97 gene associated with resistance to ganciclovir therapy

1 reference

12 December 2020

Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load

1 reference

12 December 2020

Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir

1 reference

12 December 2020

Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants

1 reference

12 December 2020

Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation

1 reference

12 December 2020

Viral prophylaxis in organ transplant patients

1 reference

12 December 2020

Immune-based therapies for cytomegalovirus infection

1 reference

12 December 2020

Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation

1 reference

12 December 2020

Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation.

1 reference

12 December 2020

Recovery of functional memory T cells in lung transplant recipients following induction therapy with alemtuzumab

1 reference

12 December 2020

Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation

1 reference

12 December 2020

Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease

1 reference

12 December 2020

Detection of simultaneous β‐herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection

1 reference

12 December 2020

High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy

1 reference

12 December 2020

Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection.

1 reference

12 December 2020

Preventing post-organ transplantation cytomegalovirus disease with ganciclovir: a meta-analysis comparing prophylactic and preemptive therapies

1 reference

12 December 2020

Less pessimistic long-term results for patients with cytomegalovirus disease

1 reference

12 December 2020

Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials.

1 reference

12 December 2020

A prospective assessment of valganciclovir for the treatment of cytomegalovirus infection and disease in transplant recipients

1 reference

12 December 2020

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

1 reference

12 December 2020

Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers

1 reference

12 December 2020

The pathogenesis of hepatitis C virus is influenced by cytomegalovirus

1 reference

12 December 2020

The Influence of Innate Immunity Gene Receptors Polymorphisms in Renal Transplant Infections

1 reference

12 December 2020

Relevance of Toll-like receptor-4 polymorphisms in renal transplantation.

1 reference

12 December 2020

Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitis

1 reference

12 December 2020

Cytomegalovirus in solid organ transplant recipients

1 reference

12 December 2020

Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation.

1 reference

12 December 2020

Efficacy and safety of preemptive anti-CMV therapy with valganciclovir after kidney transplantation

1 reference

12 December 2020

A new strategy of delayed long-term prophylaxis could prevent cytomegalovirus disease in (D+/R-) solid organ transplant recipients.

1 reference

12 December 2020

Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet

1 reference

12 December 2020

Exploring the bidirectional interactions between human cytomegalovirus and hepatitis C virus replication after liver transplantation

1 reference

12 December 2020

Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients

1 reference

12 December 2020

A trial of valganciclovir prophylaxis for cytomegalovirus prevention in lung transplant recipients.

1 reference

12 December 2020

A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients

1 reference

12 December 2020

Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art.

1 reference

12 December 2020

Association Between Mannose-Binding Lectin Deficiency and Cytomegalovirus Infection After Kidney Transplantation

1 reference

12 December 2020

T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease

1 reference

12 December 2020

Clinical features and outcomes of delayed-onset primary cytomegalovirus disease in cardiac transplant recipients

1 reference

12 December 2020

Changes in coronary arterial dimensions early after cardiac transplantation

1 reference

12 December 2020

Dynamics of Cytomegalovirus Replication during Preemptive Therapy with Oral Ganciclovir

1 reference

12 December 2020

The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients

1 reference

12 December 2020

Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study

1 reference

12 December 2020

Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children.

1 reference

12 December 2020

Leukopenia Complicates Cytomegalovirus Prevention After Renal Transplantation With Alemtuzumab Induction

1 reference

12 December 2020

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study

1 reference

12 December 2020

24-week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week course

1 reference

12 December 2020

Risk factors associated with cytomegalovirus infection in orthotopic liver transplant patients

1 reference

12 December 2020

Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis

1 reference

12 December 2020

Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests.

1 reference

12 December 2020

Treatment of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide

1 reference

12 December 2020

Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients

1 reference

12 December 2020

Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis

1 reference

12 December 2020

Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation

1 reference

12 December 2020

The association between cytomegalovirus infection and atherosclerotic events in renal transplant recipients

1 reference

12 December 2020

Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes

1 reference

12 December 2020

A lower incidence of cytomegalovirus infection in de novo heart transplant recipients randomized to everolimus.

1 reference

12 December 2020

Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir

1 reference

12 December 2020

Clinical features and outcomes of cytomegalovirus retinitis after transplantation

1 reference

12 December 2020

Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients

1 reference

12 December 2020

10.2165/10898540-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

22 August 2017

1001543221

0 references

1 reference